Risk factors in the development of Kaposis sarcoma

AIDS

Volumn 22, Issue 13, 2008, Pages 1629-1632

  Colman, Rachel ^a   Blackbourn, David J ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AIDS PATIENT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ANGIOGENESIS; B CELL LYMPHOMA; CD4 LYMPHOCYTE COUNT; EDITORIAL; ETHNICITY; GEOGRAPHIC DISTRIBUTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HLA SYSTEM; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LYMPHANGIOGENESIS; MALE HOMOSEXUAL; PREVALENCE; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; RISK FACTOR; SEX; ACQUIRED IMMUNE DEFICIENCY SYNDROME; HOMOSEXUALITY; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGY; MALE; NEOVASCULARIZATION (PATHOLOGY); NOTE; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CD4 LYMPHOCYTE COUNT; HERPESVIRUS 8, HUMAN; HOMOSEXUALITY; HUMANS; IMMUNOCOMPROMISED HOST; MALE; NEOVASCULARIZATION, PATHOLOGIC; RISK FACTORS; SARCOMA, KAPOSI;

EID: 52249104191     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283031a9f     Document Type: Editorial

References (36)

1. Wang HW, Trotter MW, Lagos D, Bourboulia D, Henderson S, Makinen T, et al. Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat Genet 2004; 36:687-693.
2. Schulz TF. The pleiotropic effects of Kaposi's sarcoma herpes-virus. J Pathol 2006; 208:187-198.
3. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266:1865-1869.
4. Boshoff C, Schulz TF, Kennedy MM, Graham AK, Fisher C, Thomas A, et al. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med 1995; 1:1274-1278.
5. Dupin N, Fisher C, Kellam P, Ariad S, Tulliez M, Franck N, et al. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci U S A 1999; 96:4546-4551.
6. Staskus KA, Zhong W, Gebhard K, Herndier B, Wang H, Renne R, et al. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol 1997; 71:715-719.
7. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS- related body-cavity-based lymphomas. N Engl J Med1995; 332:1186-1191.
8. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995; 86:1276-1280.
9. Lanternier F, Lebbé C, Schartz N, Farhi D, Marcelin AG, Kérob D, et al. Kaposi's sarcoma in HIV-negative men having sex with men. AIDS 2008; 22:1163-1168.
10. Goedert JJ, Neuland CY, Wallen WC, Greene MH, Mann DL, Murray C, et al. Amyl nitrite may alter T lymphocytes in homosexual men. Lancet 1982; 1:412-416.
11. Fung HL, Tran DC. Effects of inhalant nitrites on VEGF expression: a feasible link to Kaposi's sarcoma? J Neuroimmune Pharmacol 2006; 1:317-322.
12. Ziegler JL. Endemic Kaposi's sarcoma in Africa and local volcanic soils. Lancet 1993; 342:1348-1351.
13. Mbulaiteye SM, Biggar RJ, Pfeiffer RM, Bakaki PM, Gamache C, Owor AM, et al. Water, socioeconomic factors, and human herpesvirus 8 infection in Ugandan children and their mothers. J Acquir Immune Defic Syndr 2005; 38:474-479.
14. Coluzzi M, Calabro ML, Manno D, Chieco-Bianchi L, Schulz TF, Ascoli V. Saliva and the transmission of human herpesvirus 8: potential role of promoter-arthropod bites. J Infect Dis 2004; 190:199-200.
15. Gaya A, Esteve A, Casabona J, McCarthy JJ, Martorell J, Schulz TF, Whitby D. Amino acid residue at position 13 in HLA-DR beta chain plays a critical role in the development of Kaposi's sarcoma in AIDS patients. AIDS 2004; 18:199-204.
16. Dorak MT, Yee LJ, Tang J, Shao W, Lobashevsky ES, Jacobson LP, Kaslow RA. HLA-B, -DRB1/3/4/5, and -DQB1 gene polymorphisms in human immunodeficiency virus-related Kaposi's sarcoma. J Med Virol 2005; 76:302-310.
17. Alkharsah KR, Dedicoat M, Blasczyk R, Newton R, Schulz TF. Influence of HLA alleles on shedding of Kaposi sarcoma-associated herpesvirus in saliva in an African population. J Infect Dis 2007; 195:809-816.
18. Martro E, Esteve A, Schulz TF, Sheldon J, Gambus G, Munoz R, et al. Risk factors for human Herpesvirus 8 infection and AIDS-associated Kaposi's sarcoma among men who have sex with men in a European multicentre study. Int J Cancer 2007; 120:1129-1135.
19. Whitby D, Howard MR, Tenant-Flowers M, Brink NS, Copas A, Boshoff C, et al. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995; 346:799-802.
20. Martin DF, Kuppermann BD, Wolitz RA, Palestine AG, Li H, Robinson CA. Oral ganciclovir for patients with cytomega-lovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group. N Engl J Med 1999; 340:1063-1070.
21. RezaeeSAR, Cunningham C, Davison AJ, Blackbourn DJ. KSHV immune modulation: an overview. J Gen Virol 2006; 87:1781-1804.
22. Grundhoff A, Ganem D. Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. J Clin Invest 2004; 113:124-136.
23. Maurer T, Ponte M, Leslie K. HIV-associated Kaposi's sarcoma with a high CD4 count and a low viral load. N EnglJ Med 2007; 357:1352-1353.
24. Dukers NH, Rezza G. Human herpesvirus 8 epidemiology: what we do and do not know. AIDS 2003; 17:1717-1730.
25. Iscovich J, Boffetta P, Franceschi S, Azizi E, Sarid R. Classic kaposi sarcoma: epidemiology and risk factors. Cancer 2000; 88:500-517.
26. Guihot A, Dupin N, Marcel in AG, Gorin I, Bedin AS, Bossi P, et al. Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcoma. J Infect Dis 2006; 194:1078-1088.
27. LevyJA, ZieglerJL. Acquired immunodeficiency syndrome is an opportunistic infection and Kaposi's sarcoma results from secondary immune stimulation. Lancet 1983; 2:78-81.
28. ZongJ-C, Arav-Boger R, Alcendor DJ, Hayward GS. Reflections on the interpretation of heterogeneity and strain differences based on very limited PCR sequence data from Kaposi's sarcoma-associated herpesvirus genomes. J Clin Virol 2007; 40:1-8.
29. Blackbourn DJ, Lennette ET, AmbroziakJ, Mourich DV, LevyJA. Human herpesvirus 8 detection in nasal secretions and saliva. J Infect Dis 1998; 177:213-216.
30. Blackbourn DJ, Levy JA. Human herpesvirus 8 in semen and prostate. AIDS 1997; 11:249-250.
31. Blackbourn DJ, Osmond D, LevyJA, Lennette ET. Increased human herpesvirus 8 seroprevalence in young homosexual men who have multiple sex contacts with different partners. J Infect Dis 1999; 179:237-239.
32. Martin JN. Moving toward clarity on 2 fronts in the epidemiology of Kaposi sarcoma-associated herpesvirus i nfection. J Infect Dis 2007; 196:173-175.
33. Engels EA, Atkinson JO, Graubard BI, McQuillan GM, Gamache C, Mbisa G, et al. Risk factors for human herpesvirus 8 infection among adults in the United States and evidence for sexual transmission. J Infect Dis 2007; 196:199-207.
34. Malope BI, MacPhail P, Mbisa G, MacPhail C, Stein L, Ratshi-khopha EM, et al. No evidence of sexual transmission of Kaposi's sarcoma herpes virus in a heterosexual South African population. AIDS 2008; 22:519-526.
35. Pfeffer U, Bisacchi D, Morini M, Benelli R, Minghelli S, Vacca A, et al. Human chorionic gonadotropin inhibits Kaposi's sarcoma associated angiogenesis, matrix metalloprotease activity, and tumor growth. Endocrinology 2002; 143:3114-3121.
36. Simonart T, Van Vooren JP, Meuris S. Treatment of Kaposi's sarcoma with human chorionic gonadotropin. Dermatology 2002; 204:330-333.